Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NECTAR3: Primaquine and Tafenoquine for Malaria Transmission Reduction
NCT05081089Phase 2Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- Oct 2021
- Primary completion
- Dec 2021
- Modality
- Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of tafenoquine, primaquine in Malaria, sponsored by London School of Hygiene & Tropical Medicine. Started Oct 2021; status: completed.
02
Drugs
tafenoquineprimaquine
03
Conditions
Malaria
Beyond the preview
Go deeper on NCT05081089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05081089.